Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

motortion – stock.adobe.com “Dementia is a chronic progressive disease that is irreversible at this point. There’s no meaningful treatment that can reverse the course of the disease ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia following Alzheimer's ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues ...

In a simulated trial, the Florey Dementia Index achieved mean absolute errors of 1.57 and 0.70 years for predicting mild cognitive impairment and Alzheimer's disease onset, respectively ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

A continuous "prevention and control system for dementia, covering prevention, screening, diagnosis, treatment, rehabilitation and care, will be established by 2030", Xinhua said. The growth of ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...